Go Pro
NASDAQ:UG

United-Guardian Q4 2024 Earnings Report

United-Guardian logo
$7.08 0.00 (0.00%)
Closing price 09/25/2026 04:00 PM Eastern
Extended Trading
$7.08 +0.00 (+0.07%)
As of 09/25/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

United-Guardian EPS Results

Actual EPS
$0.11
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

United-Guardian Revenue Results

Actual Revenue
$2.48 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

United-Guardian Announcement Details

Quarter
Q4 2024
Time
Before Market Opens
Conference Call Date
Friday, March 21, 2025
Conference Call Time
9:00AM ET

United-Guardian Earnings Headlines

United-Guardian Reports Second Quarter Results
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.tc pixel
United-Guardian Declares Cash Dividend
United-Guardian Reports First Quarter Results
See More United-Guardian Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like United-Guardian? Sign up for Earnings360's daily newsletter to receive timely earnings updates on United-Guardian and other key companies, straight to your email.

About United-Guardian

United-Guardian (NASDAQ:UG) develops, manufactures, and markets specialty products for the personal care, pharmaceutical, medical, and industrial markets. The company’s products are used by manufacturers in formulations including cosmetics, skin-care products, pharmaceuticals, and medical treatments.

United-Guardian’s product portfolio includes Lubrajel, a water-soluble lubricating and moisturizing agent used in personal-care and pharmaceutical applications, as well as Renacidin, a medical solution used for the dissolution and prevention of certain urinary tract calculi and encrustations. The company also offers specialty ingredients and formulations for industrial and other commercial uses.

Based in Hauppauge, New York, United-Guardian sells its products in the United States and international markets, primarily through direct sales and distributors. The company has operated as a specialty chemical and healthcare products manufacturer for decades and emphasizes the development of proprietary formulations for established commercial applications.

View United-Guardian Profile